FDA
-
-
-
-
-
-
-
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Aziyo Biologics Reports Record Full Year 2022 Revenues
-
-
-
-
-
-
-
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation
-
-
-
-
-
-
-
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
-
-
-
-
-
-
-
Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results
-
-
-
-
-
-
-
Aziyo Biologics Announces Product Design Completion for its Next Generation CanGaroo® Envelope for Implantable Electronic Devices
-
322,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

